Odanacatib
- Generic Name
- Odanacatib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H27F4N3O3S
- CAS Number
- 603139-19-1
- Unique Ingredient Identifier
- N673F6W2VH
- Background
Odanacatib is an inhibiter of cathepsin K which was originally developed be Merck & Co as a new treatment for osteoporosis . The drug made it to phase III trials before abandoned due to increased stroke.
- Indication
Investigated for use/treatment in osteoporosis .
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath